首页> Journal of immunotherapy> Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease.

Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease.

导出原文传递

翻译打印收藏纠错

第一作者： Saleh MN

作者： Saleh MN ^[1] ; Lalisan DY Jr ^[2] ; Pride MW ; Solinger A ; Mayo MS ; LoBuglio AF ; Murray JL

作者单位： University of Alabama, Birmingham 35294-3300, USA. ^[1] ost.saga-med.ac.jp ^[2]

关键词 Antibodies Anti-Idiotypic Antigens Neoplasm Cancer Vaccines Immunotherapy Active 抗体抗独特型抗原肿瘤癌症疫苗免疫疗法主动黑色素瘤蛋白聚糖类

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of immunotherapy

1998年21卷5期

379-388页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of immunotherapy

1998年21卷5期

379-388页

检索历史清除

Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease.

Journal of immunotherapy

相似文献

同项目论文

Journal of immunotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic disease.

Journal of immunotherapy

相似文献

同项目论文

Journal of immunotherapy

相关期刊

检索历史清除